INCENDIA PHARMA
Live / Registered — Registered (as of 27 Jun 2023)
What this means for you
Registered since 27 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79329010
- Registration number
- 7088835
- Mark type
- Stylized text
- Filed
- 25 Oct 2021
- Published for opposition
- 11 Apr 2023
- Registered
- 27 Jun 2023
- Attorney of record
- Scott Rogers
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for medical, pharmaceutical or veterinary use, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceutical preparations, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceuticals, namely, gut microbiome stabilizators and quorum sensing inhibitors
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Incendia Pharma AB, SE
- Incendia Pharma AB, SE
- Incendia Pharma AB, SE
Prosecution history
- 16 Oct 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 27 Sept 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 Sept 2023 — FINAL DISPOSITION PROCESSED
- 27 Sept 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 27 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 12 Jun 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 24 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 24 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 13 Apr 2023 — NOTIFICATION PROCESSED BY IB
- 11 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Apr 2023 — PUBLISHED FOR OPPOSITION
- 22 Mar 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 22 Mar 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 22 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED